Wolters Kluwer N.V.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a WOLTF research report →
Price Chart
About the company
Wolters Kluwer N. V. , founded in 1836 and headquartered in Alphen aan den Rijn, the Netherlands, operates as a global provider of specialized information, software, and services.
- CEO
- Stacey Caywood
- IPO
- 2010
- Employees
- 20,567
- HQ
- Alphen aan den Rijn, ZH, NL
Get TickerSpark's AI analysis on WOLTF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $21.80B
- P/E
- 15.00
- Fwd P/E
- 17.83
- PEG
- 0.63
- P/S
- 3.24
- P/B
- 21.22
- EV/EBITDA
- 11.86
- Div Yield
- 2.93%
- Gross Margin
- 74.07%
- Op Margin
- 25.60%
- Net Margin
- 21.86%
- ROE
- 153.62%
- ROIC
- 17.78%
Latest fiscal year · YoY change
- Revenue
- $6.12B+3.5%
- Gross Profit
- $4.50B+4.9%
- Op Income
- $1.54B
- Net Income
- $1.31B+21.2%
- EPS
- $5.66+24.7%
- OCF Growth
- +0.9%
- FCF Growth
- +1.8%
- 52W High
- $111.04
- 52W Low
- $61.45
- 50D MA
- $85.06
- 200D MA
- $77.46
- Beta
- 0.18
- RSI (14)
- 57
- Avg Volume
- 252
Earnings call summaries
Pick a quarter — each call distilled into takeaways, results, and a bull vs bear read.
Wolters Kluwer delivered a solid first half with 5% organic growth, 100 bps margin expansion, and continued AI rollout momentum, while reaffirming full-year guidance.· August 5, 2026
- First-half revenue was EUR 3.033 billion; organic growth was 5% and 6% excluding print, with adjusted operating profit up 10% in constant currencies to EUR 893 million.
- Adjusted operating margin rose 100 bps to 29.4%, helped by operational gearing, efficiency, and the FRR divestiture; full-year margin guidance remains around 28%.
- Adjusted diluted EPS increased 14% in constant currencies to EUR 2.83, and adjusted free cash flow rose 14% to EUR 533 million.
- AI adoption is scaling across Health, Tax, and Legal, including over 90% of U.S. Enterprise Edition customers signing up for UpToDate Expert AI and around 250 accounting firms subscribing to agentic AI modules.
- Management flagged some second-half pressure from higher product development spending, slower Enablon activity in the Middle East, and continued weakness in print and some transactional revenues.
First-half 2026 revenue was EUR 3.033 billion, down 1% reported due to currency translation but up 4% in constant currencies and 5% organically. Adjusted operating profit was EUR 893 million, up 10% in constant currencies and 9% organically; adjusted operating margin improved 100 bps to 29.4%. Adjusted diluted EPS rose 14% in constant currencies to EUR 2.83, and adjusted free cash flow increased 14% in constant currencies to EUR 533 million. Health grew 5% organically, Tax & Accounting 6%, Financial & Corporate Compliance 4%, Legal & Regulatory 5%, and Corporate Performance & ESG 7%. For the full year, management reiterated margin guidance of approximately 28%, expects product development spending to be 12% to 13% of revenues and second-half weighted, and still sees high-single-digit growth in diluted adjusted EPS in constant currencies.
Stacey Caywood said the company had a good start to the year and was executing its near-term priorities of accelerating advanced AI innovation, partnerships, and go-to-market improvements. She emphasized that AI is being embedded directly into platforms with proprietary content and human-in-the-loop validation, which she framed as a key differentiator for professional customers. Her tone was confident but measured, highlighting strong renewals, recent acquisition performance, and broad-based AI rollout progress across Health, Tax, and Legal.
Kevin Entricken led with the hard numbers: EUR 3.033 billion in first-half revenue, EUR 893 million of adjusted operating profit, a 29.4% margin, EUR 2.83 adjusted diluted EPS, and EUR 533 million of adjusted free cash flow. He said the first-half margin improvement reflected operational gearing, operating efficiency programs, and FRR, while product development spend was 11% of revenues in the half and should rise to 12% to 13% for the full year. He also noted the balance sheet remains strong at 2.0x net debt-to-EBITDA, net debt was approximately EUR 4 billion, and the company is still committing to dividends and share buybacks while staying within distributable reserve limits.
Analysts focused on the size and timing of second-half margin pressure from higher product development spend, the economics of AI monetization, and whether AI adoption is translating into deeper user engagement. Management said AI is currently bundled into subscriptions, with monetization mainly coming through renewals, pricing, and add-on modules over time; on Health, they stressed that public usage data understate actual use because much usage flows through EHR integrations and ambient tools. On tax and legal, management pointed to cloud migration, agentic AI modules, Brightflag becoming organic in the second half, and Libra’s contribution later in the year as reasons for the expected second-half acceleration. They also said the Enablon slowdown is tied to Middle East uncertainty and oil & gas-related implementation delays, not a major structural change in the business.
The bull case from this call is that core growth remains solid even before the full AI benefit is realized, with 5% organic growth, strong renewals, and broad-based digital momentum in cloud, recurring, and workflow products. Management described AI adoption as early but encouraging, with meaningful rollout progress in UpToDate Expert AI, CCH Axcess agentic modules, and Libra, plus positive customer feedback and efficiency gains.
The main risks discussed were higher second-half investment spending, especially product development, which will pressure margins as management targets 12% to 13% of revenue, and some weakness in nonrecurring revenues, print, and transactional activity. Management also flagged softer Enablon activity and slower sales cycles in the Middle East, continued weakness in U.S. M&A and lending-related revenue, and competitive pressure in clinical decision support from free AI-native alternatives.
AI summary of the company's earnings call · Paraphrased · Not investment advice
- Free Float
- 97.1%
- Shares Outstanding
- 222.43M
- Float Shares
- 216.08M
Held by 13 ETFs
Biggest fund positions in WOLTF by dollar value.
Our WOLTF coverage
Recent articles, reports, and earnings notes.
No research on WOLTF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate WOLTF report →Wolters Kluwer brings TyMetrix 360° data into enterprise AI workflows with new MCP server
businesswire.com · Nov 6
New Wolters Kluwer survey highlights growing demand for trusted medication intelligence in the age of AI
businesswire.com · Nov 5
Wolters Kluwer to divest German consumer tax business
globenewswire.com · Oct 30
Wolters Kluwer LegalVIEW Insights finds billing rates tell only part of the legal cost story
businesswire.com · Oct 29
61% of companies are unprepared to handle the changes resulting from new invoicing regulations, Wolters Kluwer research shows
businesswire.com · Oct 28
Wolters Kluwer selected by IFFCO Tokio General Insurance to support Ind AS 117 and Ind AS 116 compliance with CCH® Tagetik
businesswire.com · Oct 26
Wolters Kluwer launches agentic tax preparation in CCH Axcess, the agentic platform for tax and accounting
businesswire.com · Oct 23
Wolters Kluwer partners with Inscope to launch agentic financial statement preparation in CCH Axcess
businesswire.com · Oct 22
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.